New Federal Contractors — August 21, 2026

CACI secured a $674M cost-plus-fixed-fee delivery order from GSA for IT and telecom services, providing predictable, lower-risk revenue through 2024. The full-and-open competition win signals technical merit, though 577 subawards totaling $477.8M may dilute margins.

Teledyne Brown Engineering's $371.5M NASA ISS mission support contract ended in December 2022, with actual outlays of only $151.3M (41% of obligation), indicating under-execution. No follow-on award is identified, creating a revenue gap.

BARDA awarded a $263.6M initial obligation (up to $1.04B total) to the Sabin Vaccine Institute for Marburg virus R&D. While the nonprofit recipient limits direct equity exposure, subcontractors to publicly traded biotech firms could benefit from this 10-year program.

HSGS-AMERESCO won a $149.2M firm-fixed-price delivery order from the VA for energy savings work. The fixed-price structure and 19-month performance period create high performance risk, though the SDVOSB set-aside limits competition.

HIGHRISE Consulting has already outlayed $89.6M (65%) of its $138.6M NIH IT and cloud support contract, indicating high utilization and low cancellation risk. The labor-hours pricing provides stable margins through 2027.

Teledyne Brown's NASA contract ended with only 41% of obligated funds outlayed ($151.3M of $371.5M), suggesting under-execution or delayed spending. No follow-on contract identified creates a revenue gap for Teledyne Technologies.

CACI's $674M GSA contract has a negative net outlay (-$414,919), which is unusual and may indicate early-stage accounting credits or performance issues. The contract ends May 2024, creating recompete risk.

HSGS-AMERESCO's $149M VA ESPC contract is firm-fixed-price with a tight 19-month performance period, increasing cost-overrun risk. Energy savings verification could delay payments.

The Sabin Vaccine Institute's $263M BARDA contract is a nonprofit award, limiting direct equity investment exposure. However, any subcontractors to publicly traded firms are not identified, creating information asymmetry.

CACI's $674M GSA IT services contract demonstrates strong demand for third-party IT support across civilian agencies. Investors should watch for CACI's recompete in 2024 and potential expansion into other GSA programs.

The Sabin Vaccine Institute's $1.04B BARDA contract for Marburg virus R&D signals sustained biodefense investment. Publicly traded biotech firms with vaccine platforms could benefit as subcontractors or follow-on awardees.

HSGS-AMERESCO's $149M SDVOSB set-aside from the VA highlights policy-driven opportunities for service-disabled veteran-owned small businesses in federal energy efficiency. Investors in SDVOSB-focused funds or partners could benefit.

HIGHRISE Consulting's $138M NIH IT contract with 65% outlayed demonstrates strong execution and recurring revenue visibility. Small business IT contractors with cloud expertise may see similar NIH opportunities.

Two of five contracts (CACI's $674M GSA IT and HIGHRISE's $138M NIH cloud support) total $812M in civilian IT spending, indicating stable, multi-year demand for third-party IT and cloud services across federal agencies.

BARDA's $263M award to the Sabin Vaccine Institute for Marburg virus R&D (up to $1.04B total) underscores continued government investment in emerging infectious disease countermeasures, despite the nonprofit recipient.

Teledyne Brown's $371M ISS support contract ended in 2022 with only 41% outlayed, signaling potential under-execution and no clear follow-on. NASA's shift to commercial space stations may reduce legacy ISS support demand.

{"entity" => "CACI International Inc.", "reason" => "CACI's $674M GSA IT contract ends May 2024, and the negative outlay of -$414,919 requires clarification. Recompete risk is high.", "trigger" => "Contract recompete announcement or extension in Q1 2024"}

{"entity" => "Teledyne Technologies", "reason" => "Teledyne Brown's $371M NASA contract expired in 2022 with no follow-on identified, creating a revenue gap in the space segment.", "trigger" => "Any NASA mission operations follow-on contract award or bridge extension"}

{"entity" => "Albert B. Sabin Vaccine Institute", "reason" => "The $263M BARDA contract has a 10-year performance period; option exercises will determine program continuity and potential subcontractor benefits.", "trigger" => "Option exercise announcements or BARDA budget updates for Marburg virus"}

{"entity" => "HSGS-AMERESCO, LLC", "reason" => "The $149M VA ESPC contract has a 19-month performance period ending February 2027; option exercise and cost performance are key.", "trigger" => "Option exercise by February 2027 or change order filings"}

{"entity" => "HIGHRISE CONSULTING INC", "reason" => "The $138M NIH IT contract runs through September 2027; high outlay rate (65%) suggests strong execution but renewal risk remains.", "trigger" => "NIH budget allocations for IT and cloud services in FY2025"}